Tagged: Berkeley

0

A window into the brain

When we absorb new information, the human brain reshapes itself to store this newfound knowledge. But where exactly is the new knowledge kept, and how does that capacity to adapt reflect our risk for Alzheimer’s disease and other forms of senile dementia later in our lives?

1

Phase 3 Alzheimer’s drug increases toxic beta amyloid in the brain — but still provides benefits

New insights into how a Phase III Alzheimer’s drug might work were among the advances in potential therapies targeting two abnormal brain proteins – beta amyloid and phosphorylated tau – that were reported today at the Alzheimer’s Association 2009 International Conference on Alzheimer’s Disease (ICAD 2009) in Vienna.

2

Drug rescues memory lost to Alzheimer’s disease

A drug similar to one used in clinical trials for treatment of rheumatoid arthritis and psoriasis has been found to rescue memory in mice exhibiting Alzheimer’s symptoms.

0

Brain imaging and proteins in spinal fluid may improve Alzheimer’s prediction and diagnosis

Changes in the brain measured with MRI and PET scans, combined with memory tests and detection of risk proteins in body fluids, may lead to earlier and more accurate diagnosis of Alzheimer’s, according to new research reported today at the Alzheimer’s Association 2009 International Conference on Alzheimer’s Disease (ICAD 2009) in Vienna.

0

Memory test and PET scans detect early signs of Alzheimer’s

A large study of patients with mild cognitive impairment revealed that results from cognitive tests and brain scans can work as an early warning system for the subsequent development of Alzheimer’s disease.